New updates have been reported about Hyro.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hyro has released new U.S. healthcare research showing a sharp disconnect between health system AI adoption and actual patient access, positioning its Responsible AI Agent Platform squarely at the center of a rising operational challenge. In partnership with Pixel Health and research firm Wakefield, Hyro surveyed 200 healthcare IT executives and 800 patients, finding that 91% of providers use AI in their workflows, yet 72% of patients still struggle to obtain care and over half have abandoned appointments because scheduling remains too complex.
The report highlights four key gaps that Hyro aims to address: access, proactive communication, technology readiness, and trust, with 100% of executives prioritizing access while 51% of patients have quit seeking care due to friction, and only 25% of patients report effective follow-ups versus 56% of providers who think they deliver them. Hyro CEO Israel Krush argues that generic AI tools are failing healthcare’s specific needs and underscores that Hyro’s production-grade, agentic AI is designed to streamline routing and scheduling across call centers and digital channels, reduce patient drop-off, and improve operational efficiency, creating a clearer path for health systems to convert AI investments into measurable access, revenue, and experience gains.